Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock

World News: . []

CAMBRIDGE Mass Dec 06 2018 GLOBE NEWSWIRE -- Momenta Pharmaceuticals Inc Nasdaq MNTA a biotechnology company with a validated scientific platform focused on discovering and developing novel therapeutics to treat rare immune-mediated disease...

More news and information about Momenta Pharmaceuticals, Inc.

Published By:

Globe Newswire: 01:13 GMT Friday 7th December 2018

Published: .

Search for other references to "momenta" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us